Orwell Orwell Pharmaceutical , we highly experienced in preclinical formulation and anlysis of active pharmaceutical ingredients (API), including those that present particular challenges.
we regularly help early stage companies to evaluate the physicochemical properties of their new drug, carrying out the essential groundwork for optimising the formulation and delivery method. we can then create a product that is appropriate for your needs, whether you require a fit for purpose formulation for initial preclinical safety and efficacy testing or a formulation strategy designed to help your drug progress into clinical use.
Our Preformulation capabilities include:
UNIT B-D, CROWN BUSINESS PARK, DUKESTOWN, TREDEGAR NP22, UNITED KINGDOMS